Organon & Co.
OGN· NYSE
OGNOrganon & Co.
Filed Nov 12, 2021 · 10-Q · 43 days after period end · 0001628280-21-023199
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $1.60B | $1.61B |
| Net Income | $323.00M | $547.00M |
| EPS Diluted | $1.27 | $2.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Organon & Co. · CIK 1821825 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 12, 2021 · 43 d after period end
